Welcome to our dedicated page for MSP Recovery news (Ticker: MSPR), a resource for investors and traders seeking the latest updates and insights on MSP Recovery stock.
MSP Recovery, Inc. reports developments tied to its Medicare, Medicaid, commercial and secondary payer reimbursement recovery business. The company uses data-driven technology, claim assignments and legal recovery processes to pursue reimbursements from responsible parties, and its news commonly covers litigation affecting assignment rights, recovery opportunities, operating results and technology used to identify potential recoveries.
Company updates also address public-company status matters, including material agreements, financing and restructuring discussions, capital-structure actions, shareholder voting matters, exchange-compliance actions and governance disclosures. Recent corporate-status coverage includes the conclusion of an SEC investigation without a staff recommendation for enforcement action against the company or its officers.
MSP Recovery (MSPR) has initiated claims exceeding $5.6 billion for payments due from major pharmaceutical companies. This follows an earlier announcement of $368 billion in owned claims. The company targets various recoveries, including product liability and antitrust claims, particularly against notable firms like AstraZeneca and Merck. MSPR is implementing strategies to enhance claims recovery, expecting continued growth in recovery volumes, with a total of $7.1 billion in billed amounts now being pursued.
MSP Recovery, Inc. (MSPR) announced significant updates on June 13, 2022. The company reported that the value of owned claims has surged to $368 billion. Additionally, MSPR is pursuing over $1.5 billion in claim demands from insurers. The company aims to utilize its Health Safety Technology, including biometric checks, to enhance healthcare accuracy and prevent fraud. MSPR also plans to implement this technology in Florida schools to improve safety and access to student health records. The firm highlights its rapid growth and unique expertise in healthcare data and recovery.
MSP Recovery, LLC (NASDAQ: MSPR) announced that its Founder and CEO, John H. Ruiz, purchased shares and warrants of the company. This transaction signifies Ruiz's confidence in MSP Recovery's prospects. Specific details of the purchase will be disclosed in a Form 4 filing by June 2, 2022. Since its establishment in 2014, MSP Recovery has positioned itself as a leader in Medicare, Medicaid, and secondary payer reimbursement recovery by leveraging technology to address inefficiencies in the healthcare reimbursement system. For more details, visit msprecovery.com.
MSP Recovery, LLC (MSPR) began trading on Nasdaq on May 24, 2022, after its merger with Lionheart Acquisition Corporation II (LCAP). MSPR is expanding through new revenue streams and aims to match or exceed its revenue guidance of $992 million for 2022. The company has solidified its business model through extensive due diligence, backed by over 150 entities. MSPR boasts a substantial claims portfolio of $1.5 trillion billed and $364.4 billion paid by 2021, with innovative software and litigation success in healthcare claims recovery.
MSP Recovery, Inc. (MSPR) announced that trading of its Class A Common Stock and warrants will commence on May 24, 2022 on Nasdaq following its business combination with Lionheart Acquisition Corporation II. This merger has an enterprise value of approximately $32.6 billion. MSPR has significantly increased its portfolio, reporting over $1.5 trillion in billed amounts as of December 31, 2021, reflecting a growth of over 530% since 2020. The company has also launched LifeWallet to enhance healthcare data access, aiming to improve patient outcomes.